Literature DB >> 31093731

Management opinions from different centers (Rio de Janeiro).

José Francisco M Salomão1, Tatiana Protzenko Cervante2, Antonio Rosa Bellas2.   

Abstract

INTRODUCTION: The surgical treatment of Chiari type 1 (CM1) malformation is controversial and depends largely on the preference of the surgeon. The evolution of neuroimaging resulted in an increased number of asymptomatic patients incidentally diagnosed.
PURPOSE: To study retrospectively a population of 24 symptomatic patients with CM1 operated between 1999 and 2017 in which intraoperative ultrasonography (IOUS)-assisted posterior fossa-C1 decompression was used to decide whether the dura mater should be opened (CVD+) or not (CVD).
RESULTS: Most of the patients complained of headache or neck pain, 15 had hydrosyringomyelia and 14 had some spinal cord involvement. Patients were categorized in improved, unchanged, or worse according the preoperative signs and symptoms. Overall, 19 patients improved, 3 deteriorated, and 2 remained unchanged. Among these, 4 out 5 had syringohydromyelia.
CONCLUSIONS: IOUS-assisted posterior fossa-C1 decompression is our preferred option to treat CM1. Children submitted to intradural procedures, initially or subsequently, had increased postoperative complications. CSF fistula or pseudomeningocele was the major cause of complication. The final result seems to correlate with the preoperative neurological status.

Entities:  

Keywords:  Chiari 1 malformation; Craniovertebral decompression; Hydrosyryngomyelia

Year:  2019        PMID: 31093731     DOI: 10.1007/s00381-019-04181-5

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  33 in total

1.  International survey on the management of Chiari I malformation and syringomyelia.

Authors:  Edgardo Schijman; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2004-02-14       Impact factor: 1.475

Review 2.  Chiari type I anomalies in children and adolescents: minimally invasive management in a series of 53 cases.

Authors:  L Genitori; P Peretta; C Nurisso; L Macinante; F Mussa
Journal:  Childs Nerv Syst       Date:  2000-11       Impact factor: 1.475

3.  Toward a simpler surgical management of Chiari I malformation in a pediatric population.

Authors:  M D Krieger; J G McComb; M L Levy
Journal:  Pediatr Neurosurg       Date:  1999-03       Impact factor: 1.162

4.  Incidentally identified syringomyelia associated with Chiari I malformations: is early interventional surgery necessary?

Authors:  S Nishizawa; T Yokoyama; N Yokota; T Tokuyama; S Ohta
Journal:  Neurosurgery       Date:  2001-09       Impact factor: 4.654

5.  Treatment of the Chiari malformation with bone decompression without durotomy in children and young adults.

Authors:  Hector E James; Adam Brant
Journal:  Childs Nerv Syst       Date:  2002-04-12       Impact factor: 1.475

6.  Tailored operative technique for Chiari type I malformation using intraoperative color Doppler ultrasonography.

Authors:  Thomas H Milhorat; Paolo A Bolognese
Journal:  Neurosurgery       Date:  2003-10       Impact factor: 4.654

Review 7.  Chiari I malformation associated with syringomyelia and scoliosis: a twenty-year review of surgical and nonsurgical treatment in a pediatric population.

Authors:  James M Eule; Mark A Erickson; Michael F O'Brien; Michael Handler
Journal:  Spine (Phila Pa 1976)       Date:  2002-07-01       Impact factor: 3.468

8.  Specific entities affecting the craniocervical region: syndromes affecting the craniocervical junction.

Authors:  Arnold H Menezes; Timothy W Vogel
Journal:  Childs Nerv Syst       Date:  2008-03-28       Impact factor: 1.475

9.  Chiari type I malformation in a pediatric population.

Authors:  Leslie A Aitken; Camilla E Lindan; Stephen Sidney; Nalin Gupta; A James Barkovich; Michael Sorel; Yvonne W Wu
Journal:  Pediatr Neurol       Date:  2009-06       Impact factor: 3.372

10.  Surgical results of posterior fossa decompression for patients with Chiari I malformation.

Authors:  Ramon Navarro; Greg Olavarria; Roopa Seshadri; Gabriel Gonzales-Portillo; David G McLone; Tadanori Tomita
Journal:  Childs Nerv Syst       Date:  2004-03-12       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.